Proliferative diabetic retinopathy is an advanced eye complication of diabetes that can threaten sight. New, fragile blood vessels grow in the retina and can bleed, causing floaters, blurry vision, or sudden vision loss. It tends to progress over years in people with long-standing type 1 or type 2 diabetes, and risk rises with poor glucose control and high blood pressure. Vision loss can be severe if untreated, but many people with proliferative diabetic retinopathy keep useful vision with timely care. Treatment often includes laser therapy, anti-VEGF eye injections, and sometimes surgery, along with careful control of blood sugar, blood pressure, and cholesterol.
Overview
Proliferative diabetic retinopathySymptoms
There may be no early symptoms of proliferative diabetic retinopathy, then sudden floaters, blurry or fluctuating vision, or dark curtain-like shadows. Some notice trouble seeing at night or to the side. Sudden, painless vision loss can happen from eye bleeding.
Outlook and prognosis
Many people with proliferative diabetic retinopathy keep useful vision for years when it’s found early and treated promptly. Regular eye exams, tighter glucose and blood pressure control, and timely laser or injections greatly lower the risk of severe vision loss. If bleeding or retinal detachment occurs, surgery can often stabilize or improve sight.
Causes and risk factors
Proliferative diabetic retinopathy stems from long-standing diabetes and poor glucose control. Risks rise with high blood pressure, high cholesterol, kidney disease, pregnancy, puberty, smoking, and limited access to diabetes or eye care. Family tendency and ethnic backgrounds may increase susceptibility.
Genetic influences
Genetics plays a supporting role in proliferative diabetic retinopathy. Family history and certain gene variations can raise risk and speed progression, but long-term blood sugar, blood pressure, kidney health, and duration of diabetes usually matter more.
Diagnosis
Doctors diagnose proliferative diabetic retinopathy during a dilated eye exam, looking for new vessels and bleeding. They may use retinal photos, OCT, or fluorescein angiography. Urgent referral is common once diagnosis of proliferative diabetic retinopathy is made.
Treatment and drugs
Treatment for proliferative diabetic retinopathy focuses on stopping abnormal vessel growth, sealing leaks, and protecting vision. Options often include anti-VEGF eye injections, targeted laser therapy, and vitrectomy for bleeding or scar tissue. Ongoing diabetes management and regular eye exams remain essential.
Symptoms
Vision can change quickly with proliferative diabetic retinopathy—floaters, blur, or a sudden drop that makes everyday tasks harder. You might notice small changes at first—even a few specks or dimming that comes and goes. The early symptoms of proliferative diabetic retinopathy can be subtle and then progress to sudden vision loss. Differences between eyes often stand out while driving at night, reading fine print, or after strenuous activity when bleeding is more likely.
Tiny dark specks, strings, or cobwebs drift across your view. They often come from small bleeds in the eye as fragile new vessels in proliferative diabetic retinopathy leak. Floaters may be more obvious in bright light or against a plain wall.
Vision blurs or shifts in and out of focus during the day. Small bleeds or swelling disturb how light reaches the retina. The effect can come and go, especially with activity.
Shadowed or missing areas appear in part of what you can see. Clinicians call this scotoma, which means a gap in the visual field. It can show up as a smudge you can’t blink away.
Dim rooms, dusk, or low-contrast settings feel harder to navigate. With proliferative diabetic retinopathy, scattered bleeding and scarring reduce the retina’s ability to capture faint light. Headlights and glare may feel harsher.
How people usually first notice Proliferative diabetic retinopathy?
Many people first notice proliferative diabetic retinopathy when their vision suddenly blurs, dark floaters appear like spots or cobwebs, or there are brief episodes of vision loss, especially after years of diabetes. These changes often follow no pain and may come and go at first, which can delay concern until a more dramatic bleed in the eye causes a haze or a curtain-like shadow. For others, the first signs of proliferative diabetic retinopathy are found at a routine dilated eye exam, where the eye doctor sees new, fragile blood vessels or small retinal bleeds before you notice symptoms.
Types of Proliferative diabetic retinopathy
Proliferative diabetic retinopathy (PDR) has several recognizable patterns clinicians look for, and each can affect vision in different ways. People may notice different sets of symptoms depending on their situation. Some types bring brief “missing spots” or floaters, while others cause more steady blur or trouble seeing at night. Understanding the main types of PDR can make the differences between symptom types clearer and help you and your care team talk through early symptoms of proliferative diabetic retinopathy.
High‑risk PDR
New, fragile vessels grow near the optic nerve or across the retina and are more likely to bleed. People may have no symptoms at first, then sudden floaters, haze, or a dark curtain if bleeding occurs. Vision can drop quickly when these vessels leak or scar.
NVD‑predominant
Abnormal vessels cluster on the optic disc. You might notice intermittent floaters or brief vision dimming, especially after activity, as tiny bleeds cloud the gel in the eye. Blurring often fluctuates day to day.
NVE‑predominant
Fragile vessels form elsewhere on the retinal surface. People often report new floaters and smudged central or side vision when small bleeds happen. Night or low‑contrast vision may feel worse over time.
Vitreous hemorrhage
Bleeding into the eye’s gel from fragile new vessels. Symptoms can start suddenly with showers of floaters, a reddish haze, or a gray veil across vision. One eye may be much worse while the other seems fine.
Pre‑retinal hemorrhage
Blood collects between the retina and its inner layers. People may see a horizontal dark patch that shifts slowly, with blurring that improves as the blood settles. Reading or focusing on faces can be harder until it clears.
Tractional detachment
Scar tissue from healed vessels pulls on the retina. Some notice waviness or missing areas in vision, then a shadow that spreads if the retina lifts. Straight lines can look bent, and peripheral vision may shrink.
Neovascular glaucoma
New vessels grow on the iris and drainage angle, raising eye pressure. This can cause eye pain, redness, halos around lights, and rapid blur. Light sensitivity and headache may follow when pressure spikes.
Ischemic maculopathy
Poor blood flow affects the macula, the sharp‑vision center. People may struggle with detailed tasks like reading or recognizing faces even if there are few floaters. Colors can look dulled and contrast feels reduced.
Mixed‑pattern PDR
More than one pattern appears at once, such as both disc and elsewhere vessel growth with bleeding. Symptoms can alternate between sudden floaters and ongoing blur. The balance of symptoms can shift over time.
Post‑treatment PDR
After laser, injections, or surgery, symptoms reflect healing and any remaining fragile vessels. Vision may clear as blood absorbs, but new floaters can return if vessels regrow. Regular follow‑up helps catch changes early when discussing types of proliferative diabetic retinopathy.
What genetics can tell you about symptoms
Some people with certain gene changes, like in VEGF, experience faster growth of fragile eye blood vessels that bleed and blur vision. Variants in inflammation and blood‑vessel repair genes, such as TNF‑α and ICAM1, can worsen swelling, scar tissue, and vision loss.
Causes and risk factors
Long-term high blood sugar harms the retina and triggers growth of fragile new vessels.
This process is the main cause of proliferative diabetic retinopathy.
Key risk factors for proliferative diabetic retinopathy include many years of diabetes and poor blood sugar control.
Lifestyle factors like smoking and limited access to routine eye care can add risk, and family background may also play a role.
Some risks are modifiable (things you can change), others are non-modifiable (things you can’t).
Environmental and biological risk factors
Proliferative diabetic retinopathy raises the risk of serious vision loss because fragile new blood vessels can bleed and scar the retina. Several body-based changes and some external exposures can make this stage more likely or speed it up. Doctors often group risks into internal (biological) and external (environmental). Below are key risk factors for proliferative diabetic retinopathy that clinicians watch for.
The longer you live with diabetes, the more time small retinal vessels have to become damaged and oxygen-starved. Longer duration is linked with a higher chance of progressing to proliferative diabetic retinopathy.
Persistently high blood sugar injures tiny retinal vessels and ramps up growth signals. This raises the likelihood that abnormal new vessels will form in proliferative diabetic retinopathy.
Elevated pressure strains the eye’s circulation and accelerates vessel damage. It is consistently linked to faster worsening toward proliferative diabetic retinopathy.
Diabetic kidney problems signal widespread vessel injury and higher circulating growth factors. This pattern is associated with a greater risk of proliferative diabetic retinopathy.
Genetic risk factors
Genes influence who develops proliferative diabetic retinopathy among people living with diabetes. Research shows family patterns and inherited differences in blood vessel growth, inflammation, and how the retina handles low oxygen. Put simply, genetic risk factors for proliferative diabetic retinopathy can raise or lower your personal risk even when two people have similar histories. Risk is not destiny—it varies widely between individuals.
Family history: Having close relatives with severe diabetic eye disease suggests a higher inherited risk. Studies in families and twins show that genes contribute to who progresses to the proliferative stage. This does not mean everyone in a family will be affected.
Ancestry-linked variants: Certain inherited patterns vary by ancestry and can influence risk of proliferative diabetic retinopathy. For example, variants tied to vessel growth or inflammation may be more or less common in some populations. Individual risk still depends on your unique genetic mix.
Angiogenesis genes: Differences in genes that drive new blood vessel growth can tip the balance toward fragile, abnormal vessels in the retina. Variants affecting VEGF signaling are among the most studied in people with proliferative disease.
Inflammation genes: Inherited differences in immune signaling can heighten retinal inflammation. Variants in common inflammatory messengers (such as IL-6 or TNF pathways) have been linked to progression to proliferative diabetic retinopathy in some studies. The strength of these links can vary by ancestry.
Vessel stability genes: Genes that shape the vessel wall and supporting matrix can affect leakiness and scarring. Differences in collagen, angiopoietin–TIE2, or matrix-remodeling pathways may raise risk of proliferative changes. These effects are usually small on their own but add up with other variants.
Oxygen-stress genes: Some people inherit differences in how retinal cells sense low oxygen and handle oxidative stress. Variants in HIF-1 signaling, nitric oxide production, or antioxidant defenses (like SOD2) can influence abnormal vessel growth and nerve damage. Findings are consistent with the retina’s high oxygen demand.
Renin–angiotensin genes: Inherited changes in the angiotensin-converting enzyme (ACE) system can alter local retinal blood flow and vessel growth signals. The common ACE insertion/deletion variant has been associated with proliferative diabetic retinopathy in several populations. Not all studies agree, but meta-analyses suggest a modest effect.
Mitochondrial variants: Mitochondrial DNA changes, which are passed down the maternal line, can affect energy supply and oxidative stress in the retina. Certain mitochondrial haplogroups have been linked to higher or lower risk in research cohorts. These influences may interact with nuclear genes.
Polygenic risk: Most genetic risk comes from many small-effect variants acting together. Emerging polygenic risk scores aim to combine them to estimate personal risk of proliferative diabetic retinopathy. These tools are still being refined and are not yet standard in clinics.
Lifestyle risk factors
Lifestyle habits can strongly influence how quickly proliferative diabetic retinopathy (PDR) develops or worsens. Choices that destabilize blood sugar, blood pressure, or blood lipids increase strain on the retinal microvasculature. Below are lifestyle risk factors for proliferative diabetic retinopathy and how they affect the eyes. Understanding how lifestyle affects PDR can guide safer day-to-day choices.
Frequent sugary drinks and refined carbs cause glucose spikes. Chronic hyperglycemia accelerates retinal vessel damage and abnormal new vessel growth.
Skipping meals and then overeating drives large glucose swings. High glycemic variability is linked to faster progression of diabetic retinopathy.
Low activity worsens insulin resistance and raises A1c. Regular moderate exercise improves glucose and blood pressure, which may slow PDR progression.
Nicotine and smoke toxins constrict vessels and reduce oxygen to the retina. Smokers have higher risk of retinopathy progression and bleeding events.
Risk prevention
Proliferative diabetic retinopathy risk can be lowered by steady diabetes management and routine eye care. Small, consistent habits that protect blood vessels in the eyes often make the biggest difference over time. Prevention works best when combined with regular check-ups. Work with your care team to tailor goals for blood sugar, blood pressure, and cholesterol.
Aim for consistent glucose levels day to day. Fewer spikes and dips lowers the chance mild eye changes progress to proliferative diabetic retinopathy. Your diabetes team can help set an A1C goal that is safe for you.
Keep blood pressure in your target range to protect the tiny vessels in the retina. Good control reduces the risk of worsening diabetic eye disease.
Healthy LDL and triglyceride levels support blood vessel health in the eyes. Diet changes and medicines, if needed, can help slow eye damage.
Get dilated eye exams at least once a year, or more often if advised. Many people have no early symptoms of proliferative diabetic retinopathy, so exams catch changes before vision is at risk.
Transmission
Proliferative diabetic retinopathy isn’t contagious. You can’t catch proliferative diabetic retinopathy from someone else or pass it on; it doesn’t spread through touch, the air, sex, blood, pregnancy, or breastfeeding.
Instead, proliferative diabetic retinopathy develops over time as a complication of diabetes when blood sugar stays high and damages the back of the eye. It’s not directly inherited—there’s no genetic transmission of proliferative diabetic retinopathy—though families may share a higher chance of diabetes, which can raise the risk.
When to test your genes
Consider genetic testing if you developed proliferative diabetic retinopathy unusually early, have a strong family history of severe diabetic eye disease, or features that don’t fit typical diabetes duration or control. Testing can clarify inherited risk, guide eye screening frequency, and tailor systemic care. Discuss options with an ophthalmologist and genetic counselor.
Diagnosis
Proliferative diabetic retinopathy can creep up without pain, but changes in sight can disrupt reading, driving, or recognizing faces. Doctors usually begin with a thorough eye exam and a few focused imaging tests to look for new, fragile blood vessels and related changes. When discussing how Proliferative diabetic retinopathy is diagnosed, your eye team looks for a pattern over time to confirm active disease and guide treatment.
Your eye specialist asks about vision changes like floaters, blurring, or dark spots and your diabetes history. This helps connect symptoms with possible progression to proliferative disease.
A standard eye chart measures how clearly each eye sees at distance and near. Changes in sharpness help gauge the impact of Proliferative diabetic retinopathy and guide urgency.
Drops widen the pupils so the retina can be examined in detail. The doctor looks for new abnormal blood vessels, vitreous or retinal bleeding, and scar tissue that signal proliferative disease.
Using a microscope and special lenses, the doctor closely inspects the optic nerve and retina. They assess for neovascularization, fibrous tissue, and early traction that can lead to detachment.
Stages of Proliferative diabetic retinopathy
Vision changes in proliferative diabetic retinopathy can move from quiet to urgent over time. Eye specialists group it into stages to help decide when and how to treat. Many people feel relief once they understand what’s happening. Names can differ slightly between clinics, but the stages below reflect common practice.
Early PDR
New, fragile blood vessels start growing on the retina or optic nerve but may not bleed yet. Early symptoms of proliferative diabetic retinopathy may be absent; some people notice floaters or mild blur. Close monitoring is important because bleeding can occur suddenly.
High-risk PDR
The new vessels are larger or located at the optic nerve, or there is bleeding into the jelly of the eye. This stage has a high chance of significant vision loss without prompt treatment. Doctors typically recommend urgent therapy to lower the risk of further bleeding.
Advanced PDR
Repeated bleeding and scar tissue can pull on the retina, sometimes causing a traction retinal detachment. Vision may drop sharply, and straight lines can look bent or missing. Surgery may be needed if the retina is threatened or already detached.
Outlook and prognosis
Looking at the long-term picture can be helpful. For many people with proliferative diabetic retinopathy, vision changes don’t happen all at once. You might notice more floaters after a workout, a gray curtain in part of your view, or trouble driving at night. Early care can make a real difference, especially if treatment starts when early symptoms of proliferative diabetic retinopathy first appear. Treatments like anti-VEGF eye injections, laser therapy, and timely surgery can stabilize or improve vision for many, and tight glucose, blood pressure, and cholesterol control further lowers the risk of serious vision loss.
The outlook is not the same for everyone, but most people who get regular eye exams and follow through with treatment keep usable vision in at least one eye over the long term. Prognosis refers to how a condition tends to change or stabilize over time. Without treatment, the risk of severe vision loss or blindness is high because fragile new blood vessels can bleed or cause scarring that detaches the retina. With ongoing care, many people maintain independence in daily tasks like reading, working, and getting around safely. If both eyes are affected and bleeding is repeated or scarring advances, surgery may be needed to preserve sight.
Mortality isn’t directly driven by proliferative diabetic retinopathy itself, but its presence signals long-standing diabetes and a higher risk of heart, kidney, and stroke complications. In medical terms, the long-term outlook is often shaped by both genetics and lifestyle. That’s why eye treatment goes hand in hand with whole-body care: glucose targets, blood pressure control, lipid management, no smoking, and regular activity. Talk with your doctor about what your personal outlook might look like, including how often to monitor, when to treat, and what signs should prompt a same-day call.
Long-term effects
Proliferative diabetic retinopathy can change vision slowly or in sudden steps, which can affect reading, driving, and day-to-day confidence. Long-term effects vary widely, and some people maintain stable sight while others face ongoing changes. The outlook often depends on how early the problem is found and how active the new, fragile blood vessels become. Here’s what doctors and research know about how the condition tends to unfold over time.
Vision may slowly decline or drop suddenly if bleeding or detachment occurs. Some people keep useful vision for years, while others lose detail or contrast more quickly. The pace can differ between eyes.
Fragile new vessels can bleed into the gel of the eye, causing floaters, haze, or a dark curtain. Bleeding may clear on its own but often comes back in proliferative diabetic retinopathy. Repeated episodes can chip away at overall sight.
Scar tissue can pull the retina off the back of the eye. If the center of vision lifts, the loss can be severe and sometimes permanent. Some areas may remain distorted even after repair.
New vessels can block the eye’s drain, raising pressure and causing pain and vision damage. This is a serious late complication of proliferative diabetic retinopathy. Once the nerve is harmed, vision loss from pressure cannot be reversed.
How is it to live with Proliferative diabetic retinopathy?
Living with proliferative diabetic retinopathy can feel like the world’s details are slipping away just when you need them most—street signs at dusk, a friend’s expression across the table, the fine print on a medication bottle. Day-to-day life often means extra planning for lighting, magnification tools, and safe mobility, plus keeping diabetes, blood pressure, and appointments tightly on track to protect remaining vision. For many, driving becomes limited or stops altogether, work tasks may need adaptation, and loved ones often step in with rides, help reading documents, and patience during treatment cycles like laser sessions or eye injections. Even with these challenges, people frequently build strong routines and support networks that keep independence and connection at the center of daily life.
Treatment and drugs
Proliferative diabetic retinopathy is treated with a mix of eye procedures and diabetes care to prevent bleeding, scars, and vision loss. Doctors often start with anti-VEGF eye injections to shrink fragile new vessels and reduce swelling; steroid injections may be used in select cases. Many people also need laser therapy (panretinal photocoagulation) to seal off areas that drive abnormal vessel growth, and a surgery called vitrectomy can clear persistent bleeding or scar tissue pulling on the retina. Alongside medical treatment, lifestyle choices play a role, including steady blood sugar, blood pressure, and cholesterol control, and not smoking. Ask your doctor about the best starting point for you, as the plan and timing depend on your vision, exam findings, and how active the disease is.
Non-drug treatment
Non-drug treatments for proliferative diabetic retinopathy focus on protecting sight, reducing bleeding, and slowing further damage. Laser procedures and surgery are key non-drug options, alongside day-to-day steps that steady blood sugar, blood pressure, and eye safety. Non-drug treatments often lay the foundation for long-term care, even if medicines or injections are also used. Regular eye exams help catch changes early.
A doctor uses a laser to seal off fragile new vessels and reduce the drive to grow more. This can lower the risk of severe bleeding and retinal detachment. Vision may be dimmer at night or to the sides afterward.
A surgeon removes blood-clouded gel from the eye and peels scar tissue tugging on the retina. This can restore clearer vision and reduce the chance of detachment. Recovery includes eye drops and activity limits for a short time.
Keeping glucose in target ranges helps slow eye damage over time. Work with your diabetes team on nutrition, monitoring, and activity to limit sharp ups and downs. Lifestyle changes work best when they fit your routine and goals.
Lowering high blood pressure eases strain on tiny eye vessels and lowers bleeding risk. Aim for steady, heart-healthy habits like reduced salt, regular movement, and good sleep. Your care team can tailor targets to your overall health.
Your genes may have an impact on how drugs work for you
Even with the same diagnosis, people can process eye injections and pills differently because gene variants shift how fast drugs are absorbed, activated, or cleared. These differences can affect response, dosing needs, and side‑effect risk, guiding more personalized treatment choices.
Pharmacological treatments
Proliferative diabetic retinopathy is often treated with medicines injected into the eye to calm down abnormal blood vessel growth and bleeding. These drugs mainly block a natural signal that drives new, fragile vessels to form. Not everyone responds to the same medication in the same way. While medicines won’t change early symptoms of proliferative diabetic retinopathy, they can shrink these vessels, reduce leakage, and help protect sight when used promptly and consistently.
Blocks a vessel‑growth signal (VEGF) to shrink abnormal vessels and limit bleeding. Often used monthly at first, then spaced out as the eye stabilizes. Side effects can include eye redness, floaters, or a small infection risk.
Traps VEGF and related signals to slow or stop new fragile vessels. First-line medications are those doctors usually try first, based on strong evidence and safety. Dosing may start monthly, then extend if your eye stays quiet.
Widely used because it’s effective and more affordable, though not specifically approved for eye use. Works similarly by blocking VEGF to reduce bleeding and leakage. Doctors adjust treatment plans regularly to match your response.
Targets two pathways (VEGF and Ang‑2) to stabilize leaky, fragile vessels. Some people can go longer between injections once the eye is controlled. This may help when swelling and new vessel growth occur together.
Genetic influences
Among people living with diabetes, inherited differences can affect who develops proliferative diabetic retinopathy and how quickly it progresses. Studies show that small changes across many genes—especially those that influence new blood vessel growth, inflammation, and how the retina responds to high blood sugar—can shift risk up or down. Family history is one of the strongest clues to a genetic influence. Still, genes don’t act alone: long-term blood sugar levels, high blood pressure, kidney disease, pregnancy, and smoking have a large impact, and good control can lower the chance of reaching the proliferative stage. There isn’t a single “PDR gene,” and routine genetic testing isn’t used to predict who will develop proliferative diabetic retinopathy. Researchers are testing combined scores that add up the effects of many gene changes to estimate genetic risk for proliferative diabetic retinopathy, but these tools are still being validated and aren’t part of routine care.
Is Proliferative diabetic retinopathy genetic?
Genetics plays a supporting role in proliferative diabetic retinopathy. Family history and certain gene variations can raise risk and speed progression, but long-term blood sugar, blood pressure, kidney health, and duration of diabetes usually matter more.
Pharmacogenetics—how genetics influence drug effects
Treatments for proliferative diabetic retinopathy often include anti-VEGF eye injections to calm abnormal vessel growth, but people don’t all respond the same way or need the same number of visits. Not every difference in response is genetic, but research suggests that inherited differences in the VEGF pathway and related genes may affect how strongly these drugs work or how often injections are needed. These are early findings, and there isn’t a validated genetic test yet to pick the “right” anti-VEGF drug or dose for proliferative diabetic retinopathy. Because the medicine is placed directly into the eye, the usual drug‑metabolism genes in the liver matter less than they do for pills, though they could still play a role in rare whole‑body side effects; that link hasn’t been confirmed for PDR. For now, doctors base decisions on what they see in the retina, your past response, and overall diabetes control, rather than on genetic testing. As studies expand, genetics may help predict response to anti‑VEGF treatment for proliferative diabetic retinopathy and decrease trial and error, but this isn’t part of routine care today.
Interactions with other conditions
High blood pressure, kidney disease, and obstructive sleep apnea can all speed up damage in the retina, making eye bleeding and scar tissue more likely to develop or worsen. Proliferative diabetic retinopathy also tends to track with heart and blood vessel problems, and its presence can signal higher overall cardiovascular risk. Doctors call it a “comorbidity” when two conditions occur together, and in diabetes, retinopathy often overlaps with kidney problems and nerve issues, which can complicate both treatment timing and recovery.
Other eye conditions matter, too: cataracts can blur vision and mask early symptoms of proliferative diabetic retinopathy, and pressure problems in the eye can lead to neovascular glaucoma after new, fragile vessels grow. Anemia and pregnancy can increase the eye’s oxygen demand, which may accelerate progression, so closer monitoring is usually advised during these times. Interactions can look very different from person to person, so coordinated care between your diabetes team, heart and kidney specialists, and an eye doctor helps tailor safe treatment choices and follow-up.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described sudden changes in sight—dark floaters, hazy patches, or curtain‑like shadows—often after years of living with diabetes. Healers noticed that vision problems seemed to arrive late and progress quickly, which today we recognize as a hallmark of proliferative diabetic retinopathy. Families and communities once noticed patterns in which older relatives with longstanding diabetes lost vision, while younger relatives with newer diagnoses did not, hinting at a timeline that medicine would later confirm.
From early written records to modern studies, clinicians first relied on what they could see with simple handheld lights: fragile new blood vessels on the retina, small bleeds in the back of the eye, and scar tissue that tugged on the delicate seeing surface. Early reports called it “new vessel disease,” though the term has shifted as imaging improved and understanding deepened. Before insulin was introduced in the 1920s, people with diabetes often developed complications earlier; as survival improved, eye disease became more visible and better studied.
As medical science evolved, the 1960s and 1970s brought careful photographic documentation of the retina, allowing doctors to follow changes over time and separate milder stages from this advanced, “proliferative” stage. Researchers then tested treatments aimed at stopping those fragile vessels from growing. Panretinal laser therapy emerged as a major step, showing that timely treatment could lower the risk of severe vision loss. With each decade, specialized techniques improved: safer lasers, more precise eye imaging, and vitrectomy surgery to clear blood or repair traction when needed.
In recent decades, awareness has grown around controlling blood sugar, blood pressure, and cholesterol to slow or prevent proliferative diabetic retinopathy. Large, long-term studies confirmed that steady glucose management and regular eye exams make a real difference, shifting care toward prevention and earlier intervention. More recently, medicines injected into the eye that block vessel‑growth signals have added another option to help quiet active disease and reduce bleeding.
Historical differences highlight why screening remains essential. Many living with diabetes feel no eye symptoms until proliferative diabetic retinopathy is already advanced. That lesson—from eras when sight could fade without warning—has shaped today’s guidance for routine dilated eye exams, even when vision seems fine. Over time, the way the condition has been understood has changed, but the core message has stayed steady: early detection and timely treatment can help protect sight.